An international perspective on low-dose aspirin for the primary prevention of myocardial infarction. (15th February 2023) - Dasa, Osama
Highlights: When using aspirin for primary prevention: Updated risk assessment tools are needed to estimate a favorable risk-benefit profile. CVD risk calculators should include other risk enhancers to reclassify patients. A validated bleeding-risk tool is needed.